FOLEY & LARDNER LLP

Lobbying for COHERUS BIOSCIENCES · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Government Issues

Issues related to federal drug reimbursement and domestic manufacturing policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem